Alternative Gingival De-Epithelialization Techniques

Sponsor
University of Michigan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05947305
Collaborator
Delta Dental Foundation (Other)
48
1
4
13
3.7

Study Details

Study Description

Brief Summary

The goal of this clinical trial is to compare different de-epithelialization methods in patients undergoing soft tissue augmentation surgery. The main questions it aims to answer are:

• Which technique is superior for de-epithelialization in terms of remaining epithelium, wound healing of the donor site, and clinical outcomes?

Condition or Disease Intervention/Treatment Phase
  • Procedure: Surgical Blade
  • Procedure: Mucotome
  • Procedure: Diamond Bur
  • Procedure: Er:YAG Laser
N/A

Detailed Description

Participants will be randomly assigned to one of four surgical techniques during their surgical procedure and the wound site will be assessed on post-operative days 1, 7, 14, and 21.

Researchers will compare the use of mucotome, Er:YAG laser, surgical diamond bur, or blade to observe patterns of wound healing and assess if one method is superior in terms of removing the epithelium.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Alternative Gingival De-Epithelialization Techniques: A Randomized Controlled Trial
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Surgical Blade

A surgical blade will be used to de-epithelialize gum tissue during the subject's regularly scheduled dental surgery.

Procedure: Surgical Blade
Using a 15c blade to de-epithelialize the soft tissue extra-orally

Experimental: Mucotome

A mucotome will be used to de-epithelialize gum tissue during the subject's regularly scheduled dental surgery.

Procedure: Mucotome
Using Megagen Mucotome to de-epithelialize the soft tissue intra-orally

Experimental: Diamond Bur

A diamond bur will be used to de-epithelialize gum tissue during the subject's regularly scheduled dental surgery.

Procedure: Diamond Bur
Using a surgical diamond bur to de-epithelialize the soft tissue intra-orally

Experimental: Er:YAG Laser

A dental laser will be used to de-epithelialize gum tissue during the subject's regularly scheduled dental surgery.

Procedure: Er:YAG Laser
Using an Er:YAG Laser to de-epithelialize the soft tissue intra-orally

Outcome Measures

Primary Outcome Measures

  1. Histomorphometric Comparison [After Day 0 (Baseline surgery)]

    Histomorphometric evaluation of the relative proportion of epithelial tissue remnants (percentage) after de-epithelialization of the CTG

Secondary Outcome Measures

  1. Surgical Time [Day 0 (Baseline Surgery)]

    Time spent removing the epithelium (in minutes)

  2. Patient-reported outcome measures [Days 1, 7, 14, 21 (Post-operative) after surgery]

    Patient-reported outcome measures regarding pain and discomfort after the procedure using a line scale (from no pain to worst pain imaginable), box scale (ranging from 0-10 with 0 being no pain and 10 being worst pain imaginable), and a verbal rating scale (no pain, slightly painful, moderately painful, very painful, extremely painful). The number of analgesics (along with dosage) taken during the post-operative period will be recorded.

  3. Wound healing [Days 1, 7, 14, 21 (Post-operative) after surgery]

    Wound healing comparisons using a clinical healing index (CHI) developed by Pippi et al 2015 will be completed. The possible total score is 7 (ideal score demonstrating ideal healing = 0), with scores for each section being dichotomous (0 or 1). Parameters related to clinical inspection include: mucosal color, granulation tissue, epithelialization degree, and swelling. Palpation parameters include bleeding, pain, and suppuration.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • American Society of Anesthesiologists (ASA) Physical Status Classification I or II

  • Subjects undergoing periodontal surgical procedures that involve harvesting of soft tissue samples, who have a treatment plan including the use or removal of keratinized mucosa or subepithelial connective tissue that will not require additional anesthesia for sample collection

  • Adequate physical and mental health to undergo routine dental treatment

  • Ability and willingness to follow instructions related to the study procedures

Exclusion Criteria:
  • Poorly controlled diabetes, defined as HbA1c >/= 7.0

  • Autoimmune or inflammatory conditions such as systemic lupus erythematous, rheumatoid arthritis.

  • Pregnant women or nursing mothers, or unsure of pregnancy status (self-reported)

  • Severe hematologic disorders, such as leukemia or hemophilia

  • Subjects on anticoagulant or antiplatelet therapy

  • Local or systemic infection that may interfere with healing

  • Hepatic or renal diseases

  • Currently under cancer treatment or within 18 months from completion of radio- or chemotherapy

  • History of antibiotic or immunosuppressant use in the last 3 months

  • Subjects on concomitant drug therapy for systemic conditions that may affect outcomes of the study

  • Current smokers (CDC definition): heavy smokers: subjects who have smoked >10 cigarettes per day within 6 months of study onset, and have smoked >100 cigarettes in their lifetime

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan School of Dentistry Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan
  • Delta Dental Foundation

Investigators

  • Principal Investigator: Sandra Stuhr, DMD, MS, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sandra Hyon Mi Stuhr, Clinical Assistant Professor of Dentistry, Periodontics and Oral Medicine, University of Michigan
ClinicalTrials.gov Identifier:
NCT05947305
Other Study ID Numbers:
  • HUM00231789
First Posted:
Jul 17, 2023
Last Update Posted:
Jul 17, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 17, 2023